Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial
Mancilla-Galindo et al., Frontiers in Medicine, doi:10.3389/fmed.2023.1256197
https://c19early.org/mancillagalindo2.html